Microglial senescence in Alzheimer and Parkinson disease progression

PARTIALLY ADDRESSED

What are the mechanisms by which microglial senescence contributes to Alzheimer disease and Parkinson disease progression, and what therapeutic strategies could target senescent microglia?

Priority: 0.85 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Microglial senescence in Alzheimer and Parkinson disease progression is a 0.85 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Microglial senescence in Alzheimer and Parkinson disease progression — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
1
Debates
0.50
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (16)

P62→AlzheimerAlzheimer→MtorAlzheimer→EpigeneticGENES→ParkinsonDNA→Alzheimer
▸ Show 11 more

associated with (12)

Alzheimer→AutophagyNeuroinflammation→ParkinsonParkinson→ApoptosisDiabetes→AlzheimerAmyotrophic Lateral Sclerosis→Parkinson
▸ Show 7 more

biomarker for (2)

NFL→AlzheimerGFAP→Alzheimer

expressed in (3)

APOE4→AlzheimerAPOE→AlzheimerTREM2→Alzheimer

regulates (6)

GENES→ParkinsonAlzheimer→Lipid MetabolismGENES→AlzheimerAKT→AlzheimerAPOE→Alzheimer
▸ Show 1 more

therapeutic target (11)

Alzheimer→Lipid MetabolismAlzheimer→Immune ResponseAlzheimer→Blood-Brain BarrierParkinson→Blood-Brain BarrierOVERVIEW→Alzheimer
▸ Show 6 more
🕑 Activity Feed
🎭 Microglial senescence in Alzheimer and Parkinson disease pro q=0.50 2026-04-25T23:55
✏ update on knowledge_gap by None 2026-04-25T23:43
✏ update on knowledge_gap by None 2026-04-25T23:43
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps